Pharmala Biotech Holdings, Inc. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Crescita Therapeutics, Inc.

Æterna Zentaris, Inc.

Medicure, Inc.

Telescope Innovations Corp.

Valeo Pharma, Inc.

PreveCeutical Medical, Inc.

Pharmala Biotech Holdings, Inc.

PharmaTher Holdings Ltd.

Core One Labs, Inc.

Revive Therapeutics Ltd.

XORTX Therapeutics, Inc.

Why is Pharmala Biotech Holdings, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Pharmala Biotech Holdings, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Pharmala Biotech Holdings, Inc.

-45.95%

0.11

116.34%

S&P/TSX 60

21.87%

1.43

14.72%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

11.84%

EBIT Growth (5y)

14.14%

EBIT to Interest (avg)

-2.14

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.49

Sales to Capital Employed (avg)

0.44

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

5.05

EV to EBIT

-5.42

EV to EBITDA

-5.74

EV to Capital Employed

7.34

EV to Sales

11.12

PEG Ratio

Dividend Yield

ROCE (Latest)

-135.57%

ROE (Latest)

-86.00%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

Bullish

No Signal

Bollinger Bands

Bearish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company

NET SALES(HY)

At CAD 0.47 MM has Grown at 331.29%

OPERATING PROFIT(Q)

Highest at CAD -0.31 MM

PRE-TAX PROFIT(Q)

Highest at CAD -0.34 MM

NET PROFIT(Q)

Highest at CAD -0.34 MM

-6What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CAD -0.92 MM

ROCE(HY)

Lowest at -98.51%

RAW MATERIAL COST(Y)

Grown by 170.34% (YoY

Here's what is working for Pharmala Biotech Holdings, Inc.

Net Sales

At CAD 0.47 MM has Grown at 331.29%

Year on Year (YoY)

MOJO Watch

Sales trend is very positive

Net Sales (CAD MM)

Operating Profit

Highest at CAD -0.31 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CAD MM)

Pre-Tax Profit

Highest at CAD -0.34 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CAD MM)

Net Profit

Highest at CAD -0.34 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CAD MM)

Here's what is not working for Pharmala Biotech Holdings, Inc.

Operating Cash Flow

Lowest at CAD -0.92 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CAD MM)

Raw Material Cost

Grown by 170.34% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales